Northern Trust Corp Clene Inc. Transaction History

Northern Trust Corp

$572 Billion
Q1 2024

A detailed history of Northern Trust Corp transactions in Clene Inc. stock. As of the latest transaction made, Northern Trust Corp holds 169,225 shares of CLNN stock, worth $55,844. This represents 0.0% of its overall portfolio holdings.

Number of Shares

169,225

Previous 165,499 2.25%

Holding current value

$55,844

Previous $49,000 46.94%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$0.28 - $0.53 $1,043 - $1,974	3,726 Added 2.25%	169,225 $72,000
Q4 2023 Feb 13, 2024	BUY	$0.26 - $0.55 $15,324 - $32,416	58,939 Added 55.31%	165,499 $49,000
Q3 2023 Nov 13, 2023	BUY	$0.46 - $0.87 $28,423 - $53,757	61,790 Added 138.02%	106,560 $53,000
Q1 2023 May 15, 2023	BUY	$0.95 - $1.62 $7,218 - $12,308	7,598 Added 20.44%	44,770 $50,000
Q3 2022 Nov 14, 2022	BUY	$0.33 - $4.83 $352 - $5,158	1,068 Added 2.96%	37,172 $104,000

Q2 2022 Aug 12, 2022	SELL	$2.1 - $4.12 $298,666 - $585,954	-142,222 Reduced 79.75%	36,104 $91,000
Q1 2022 May 13, 2022	SELL	$2.42 - $4.42 $19,546 - $35,700	-8,077 Reduced 4.33%	178,326 $703,000
Q4 2021 Feb 08, 2022	BUY	$3.95 - $7.53 $797 - $1,521	202 Added 0.11%	186,403 $764,000
Q3 2021 Nov 15, 2021	BUY	$6.83 - $13.58 $706,433 - $1.4 Million	103,431 Added 124.96%	186,201 $1.27 Million
Q2 2021 Aug 13, 2021	BUY	$6.98 - $13.33 $296,817 - $566,844	42,524 Added 105.66%	82,770 $931,000
Q1 2021 May 12, 2021	BUY	$6.39 - $16.3 $257,171 - $656,009	40,246 New	40,246 $514,000

Others Institutions Holding CLNN

# of Institutions

Shares Held

7.44M

Call Options Held

48.1K

Put Options Held

160K

View Full List

About Clene Inc.

Ticker CLNN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,502,000
Market Cap $21M
Description
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...

More about CLNN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Clene Inc. Transaction History